The Atherogenic Index of Plasma as a Novel Marker of Critical Multivessel Disease in Non-ST-Elevation Myocardial Infarction Non-ST Yükselmeli Miyokard Enfarktüsünde Kritik Çok Damar Hastalığının Yeni Bir Belirteci Olarak Plazma Aterojenik İndeksi
Turk Kardiyoloji Dernegi Arsivi, cilt.54, sa.3, ss.245-252, 2026 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 54 Sayı: 3
- Basım Tarihi: 2026
- Doi Numarası: 10.5543/tkda.2025.41820
- Dergi Adı: Turk Kardiyoloji Dernegi Arsivi
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Central & Eastern European Academic Source (CEEAS), EMBASE, Directory of Open Access Journals, TR DİZİN (ULAKBİM), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest)
- Sayfa Sayıları: ss.245-252
- Anahtar Kelimeler: Acute coronary syndrome, atherogenic index of plasma, multivessel coronary artery disease, non-ST-segment elevation myocardial infarction, predictors
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objective: This study aimed to determine whether the atherogenic index of plasma (AIP) can predict critical multivessel coronary artery disease (MVD) in patients presenting with non-ST-segment elevation myocardial infarction (NSTEMI). Method: In this retrospective analysis, patients diagnosed with NSTEMI who underwent coronary angiography between January and December 2024 were evaluated. Based on angiographic findings, patients were classified according to the number of major epicardial vessels with significant stenosis, and MVD was defined as critical involvement of all three major vessels. The AIP was calculated as log (triglyceride/high-density lipoprotein [HDL]-cholesterol). Multivariable logistic regression analysis was used to identify independent predictors of MVD, and receiver operating characteristic (ROC) curve analysis was performed to assess diagnostic accuracy. Results: Of the 1,216 patients included in the study, 302 (24.8%) had MVD. Those with critical MVD had significantly higher AIP values than those without MVD (0.74 ± 0.28 vs. 0.59 ± 0.26, P < 0.001). In multivariable analysis, AIP remained an independent determinant of MVD (odds ratio: 3.132, 95% confidence interval: 1.626-6.030, P = 0.001). Diabetes mellitus, higher hemoglobin A1c (HbA1c), and elevated low-density lipoprotein (LDL)-cholesterol levels were also independently associated with MVD. AIP demonstrated moderate discriminative ability for predicting MVD, with an area under the curve (AUC) of 0.689 and sensitivity and specificity of 65.6%. Conclusion: AIP was independently associated with the presence of critical MVD in patients with NSTEMI. Given its simplicity, affordability, and accessibility, AIP may serve as a practical indicator of atherogenic burden and help identify patients who are more likely to have multivessel coronary involvement.